Clinical Trial

Trial of JYB1904 in Chronic Spontaneous Urticaria.

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated November 29, 2024 (before its estimated July 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
This Phase II Trial is Meant to Evaluate the Efficacy, Safety and Tolerability of JYB1904 Injection in Patients With Chronic Spontaneous Urticaria.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-07-13.
Status change: Not Yet Recruiting → Recruiting 2024-11-26
Trial Details
NCT Number NCT06509334
Lead Sponsor Jemincare
Conditions Chronic Spontaneous Urticaria
Enrollment 135 participants
Start Date 2024-08-04
Primary Completion 2026-07-15 (estimated)
Study Completion 2026-07-15 (estimated)
Updated on ClinicalTrials.gov 2024-11-29